Fig. 1

SARS-CoV-2 infection leads to increased expression of HDAC6. A VERO E6 cells (at a MOI of 1), B Calu-3 cells (at a MOI of 1) and C A549 cell (at a MOI of 2) infected with SARS-CoV-2 or kept mock-infected were harvested at indicated time post-infection (18, 32, and 40 hpi) and cellular lysates were prepared. Lysates were run on SDS-PAGE followed by western blot analysis using anti-HDAC6 antibody. GAPDH and NSP13 were used as internal loading control and SARS-CoV-2 infection marker respectively